With the receipt of Hart-Scott-Rodino clearance, the previously announced acquisition of Precision Dermatology by Valeant Pharmaceuticals International, Inc. for $500 million, closed July 7, 2014.
Read Full Release

Onset Dermatologics, a PreCision Dermatology company and a leader in developing and commercializing prescription products for improving skin health, today announced the acquisition of Clindagel® from Galderma Laboratories.
Read Full Release